Literature DB >> 120383

Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis.

M J Thomassen, C A Demko, B Boxerbaum, R C Stern, P J Kuchenbrod.   

Abstract

Clinical isolates of Pseudomonas aeruginosa from patients with cystic fibrosis were studied in an effort to determine the unique characteristics of the infecting strains and to elucidate the pattern of colonization. Of 413 patients studied, 81% were chronically infected with P. aeruginosa. Patients from whom P. aeruginosa was never or only occasionally isolated were in better clinical condition than the chronically infected patients. Isolates were classified into six morphologic varieties: classic, rough, mucoid, gelatinous, dwarf, and enterobacter. Most patients had two or more of these varieties. Such multiple varieties from the same individual were of the same serotype but often differed in antibiotic susceptibility as determined by both the disk and the minimal inhibitory concentration methods. These differences were apparent when mucoid strains were compared with nonmucoid strains and when nonmucoid strains were compared with one another. Studies of antibiotic susceptibility should be performed on each morphologically different type of P. aeruginosa obtained from patients with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 120383     DOI: 10.1093/infdis/140.6.873

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  51 in total

1.  Role of an alginate lyase for alginate transport in mucoid Pseudomonas aeruginosa.

Authors:  Sumita Jain; Dennis E Ohman
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Clinical characteristics associated with isolation of small-colony variants of Staphylococcus aureus and Pseudomonas aeruginosa from respiratory secretions of patients with cystic fibrosis.

Authors:  Michael Schneider; Kathrin Mühlemann; Sara Droz; Sabine Couzinet; Carmen Casaulta; Stefan Zimmerli
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

3.  Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa.

Authors:  R A Hatch; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis.

Authors:  H Gilljam; A S Malmborg; B Strandvik
Journal:  Thorax       Date:  1986-08       Impact factor: 9.139

5.  Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.

Authors:  D P Speert; M E Campbell; S W Farmer; K Volpel; A M Joffe; W Paranchych
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

6.  Entropically driven aggregation of bacteria by host polymers promotes antibiotic tolerance in Pseudomonas aeruginosa.

Authors:  Patrick R Secor; Lia A Michaels; Anina Ratjen; Laura K Jennings; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

7.  Risk of cross-colonization and infection by Pseudomonas aeruginosa in a holiday camp for cystic fibrosis patients.

Authors:  J A Hoogkamp-Korstanje; J F Meis; J Kissing; J van der Laag; W J Melchers
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

8.  Pseudomonas aeruginosa cystic fibrosis isolates from individual patients demonstrate a range of levels of lethality in two Drosophila melanogaster infection models.

Authors:  Erika I Lutter; Monica M P Faria; Harvey R Rabin; Douglas G Storey
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

9.  Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.

Authors:  M J Struelens; V Schwam; A Deplano; D Baran
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

Review 10.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.